Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genexo
Warsaw, Mazowieckie, Polandgenexo.pl ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Genexo is a Polish pharmaceutical and medical device company specializing in diabetology and home diagnostics. Founded in 2002, the company offers high-quality blood glucose monitoring systems, glucometers, blood pressure monitors, thermometers, and inhalers, alongside prescription and OTC drugs, cosmetics, and dietary supplements. Genexo is known for introducing innovative solutions to the Polish market, such as the first glucometer with a speaker function for visually impaired patients. The company is a portfolio company of Twiti Investments and was one of the co-founders of the Polish biotechnology company Mabion.
- Therapeutic areas
- Metabolic DisordersCardiovascularEndocrinology
- Modalities
- Small moleculeDevice
- Industry
- Pharma
02
Partnerships
EnzymotecTaiDoc Technology CorporationTempraMed
Beyond the preview
Go deeper on Genexo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genexo.